Table 3 Paired samples t-test comparison of the means in terms of medication in both groups
From: Preliminary results of Preserflo Microshunt versus Preserflo Microshunt and Ologen implantation
Follow Up | Intervention | n | Mean ± SD | Std. Error | 95% Confidence interval | P |
|---|---|---|---|---|---|---|
Baseline | Group A | 25 | 2.52 ± 0.91 | 0.19 | 2.10 to 2.89 | 0.70 |
Group B | 25 | 2.58 ± 0.82 | 0.16 | 2.23 to 2.93 | ||
1 Day | Group A | 25 | 0.00 ± 0.00 | 0.00 | 0.00 to 0.00 | 0.00 |
Group B | 25 | 0.00 ± 0.00 | 0.00 | 0.00 to 0.00 | ||
2 Weeks | Group A | 25 | 0.00 ± 0.00 | 0.00 | 0.00 to 0.00 | 0.00 |
Group B | 25 | 0.00 ± 0.00 | 0.00 | 0.00 to 0.00 | ||
1 Month | Group A | 25 | 0.00 ± 0.00 | 0.00 | 0.00 to 0.00 | 0.00 |
Group B | 25 | 0.00 ± 0.00 | 0.00 | 0.00 to 0.00 | ||
3 Months | Group A | 25 | 0.00 ± 0.00 | 0.00 | 0.00 to 0.00 | 0.00 |
Group B | 25 | 0.00 ± 0.00 | 0.00 | 0.00 to 0.00 | ||
6 Months | Group A | 25 | 0.04 ± 0.20 | 0.04 | −0.04 to 0.12 | 0.47 |
Group B | 25 | 0.16 ± 0.66 | 0.16 | −0.17 to 0.51 |